Glaxo Sees More Competitive Shifts by U.S. Payers

Feb. 5 (Bloomberg) -- Simon Dingemans, chief financial officer at GlaxoSmithKline Plc, discusses the drugmaker's growth, new products and maintaining competitiveness in the U.S. He speaks with Bloomberg's Makiko Kitamura in London. (Source: Bloomberg)

BAML Plans to Short Pound Ahead of Brexit Talks
55:21 - Thanos Vamvakidis, head of G10 FX Strategy at Merrill Lynch, discusses Brexit and his outlook for the British pound. He speaks on "Bloomberg Daybreak: Europe." (Source: Bloomberg)
  • Suspected Terrorist Attack Kills 19 at Concert for Teens
  • At Least 19 People Were Killed at Concert
  • Z/Yen Says London Still Tops Financial Centres Index